Dr. Thomas Peter Greco, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 133 Scovill St, Suite 306, Waterbury, CT 06706 Phone: 203-709-3667 Fax: 203-709-3663 |
Tooba Munawar, MD Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 56 Franklin St, Waterbury, CT 06706 Phone: 203-709-6000 |
Dr. David N Podell, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 64 Robbins St, Rheumatology, Third Floor, Waterbury, CT 06708 Phone: 203-573-7281 Fax: 203-573-7230 |
Dr. Brian Peck, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1389 W Main St, Suite 120, Waterbury, CT 06708 Phone: 203-755-5555 Fax: 203-573-8523 |
News Archive
Researchers aim to better understand the population-level thrombotic risks post COVID-19 vaccination with both the ChAdOx1-S and BNT162b2 vaccines.
In the arms race between bacteria and modern medicine, bacteria have gained an edge. In recent decades, bacterial resistance to antibiotics has developed faster than the production of new antibiotics, making bacterial infections increasingly difficult to treat. Scientists worry that a particularly virulent and deadly "superbug" could one day join the ranks of existing untreatable bacteria, causing a public health catastrophe comparable with the Black Death.
The Associated Press: Democrats, "running scared in an election year," are hopeful that a $250 check - to help seniors afford prescription drugs - will turn the tide of public opinion. "Democrats ... are trying to overcome older people's mistrust of the new health care law, which expands coverage for younger generations by cutting Medicare payments to hospitals and insurers. … Behind the hoopla, the reality is modest. The $250 check, for example, is just a fraction of what many people in the prescription coverage gap have to pay.
Pfizer Inc. today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for bazedoxifene/conjugated estrogens (BZA/CE), a potential new medicine for postmenopausal women with a uterus for the treatment of estrogen deficiency symptoms and treatment of osteoporosis in women at risk of fracture.
Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.
› Verified 3 days ago